IUX24
TopMarketWorldEconomyFinanceTechnologyBusinessPoliticsAnalysis & Opinion

Windward Bio files for US IPO

Swiss drug developer Windward Bio has filed for a US initial public offering on Nasdaq. The company develops antibody treatments for asthma and inflammatory skin conditions. It aims to list its shares under the symbol WWB.

Xurve View
Insights:

Windward Bio filed for a US IPO on Friday evening, joining a late-year surge of biotech listings. The Basel-based drug developer has secured $365 million from backers including Novo Holdings. The offering highlights renewed investor demand for clinical-stage respiratory treatments despite broader market volatility.

Pipeline and Backing
IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.